Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Leiming Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6735-4853; OpenAlex author ID A5103197584. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
21
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers

Papers 10

  1. Photodynamic Therapy Using RGD-Functionalized Quantum Dots Elicit a Potent Immune Response in a Syngeneic Mouse Model of Pancreatic Cancer. Last author DOI 10.2147/ijn.s479123↗
  2. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma. Last author DOI 10.3748/wjg.v30.i19.2575↗
  3. Self-Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic Cancer. Co-author DOI 10.1002/adma.202305798↗
  4. Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer. Co-author DOI 10.1002/advs.202002746↗
  5. Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression. Last author DOI 10.3748/wjg.v26.i26.3737↗
  6. Effect of photodynamic therapy with (17R,18R)-2-(1-hexyloxyethyl)-2-devinyl chlorine E6 trisodium salt on pancreatic cancer cells in vitro and in vivo. Last author DOI 10.3748/wjg.v24.i46.5246↗
  7. TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1. Co-author DOI 10.1038/srep45895↗
  8. CdSe/ZnS quantum dots induce photodynamic effects and cytotoxicity in pancreatic cancer cells. Last author DOI 10.3748/wjg.v22.i21.5012↗
  9. NEAT1 regulates pancreatic cancer cell growth, invasion and migration though mircroRNA-335-5p/c-met axis. Last author PMID 27822425↗
  10. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo. Co-author DOI 10.1371/journal.pone.0144969↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiaxing Pan · 3 shared papers, 2023–2024 · strength 0.61
  2. Fang Zhen Sun · 4 shared papers, 2018–2024 · strength 0.52
  3. Jia-Chun Yang · 5 shared papers, 2015–2024 · strength 0.47
  4. Jia Cao · 5 shared papers, 2015–2018 · strength 0.31
  5. Yi Zhang · 4 shared papers, 2016–2020 · strength 0.31
  6. Haijun Yu · 2 shared papers, 2021–2023 · strength 0.30
  7. Zhiai Xu · 2 shared papers, 2021–2023 · strength 0.30
  8. Mingming Li · 2 shared papers, 2017–2024 · strength 0.28
  9. Peng Tian · 1 shared paper, 2024 · strength 0.23
  10. Nannan Zheng · 2 shared papers, 2018–2020 · strength 0.19
  11. Feng Wang · 1 shared paper, 2023 · strength 0.18
  12. Yujie Shen · 1 shared paper, 2018 · strength 0.07
  13. Hui Wang · 1 shared paper, 2017 · strength 0.07
  14. Yi Zhang · 1 shared paper, 2017 · strength 0.07
  15. Ying Chen · 1 shared paper, 2016 · strength 0.06
  16. Yongsheng Li · 1 shared paper, 2016 · strength 0.05
  17. Sijia He · 1 shared paper, 2016 · strength 0.05
  18. Thiruvengadam Arumugam · 1 shared paper, 2015 · strength 0.05
  19. Zhao‐Shen Li · 1 shared paper, 2015 · strength 0.05
  20. Vijaya Ramachandran · 1 shared paper, 2015 · strength 0.05
  21. Craig D. Logsdon · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.